妊娠期百日咳免疫接种:抗体水平与加强疫苗的影响
66%曾接种百日咳疫苗,其中82名孕期接种。近期接种者抗体滴度显著更高,95.1%抗PT IgG>10 IU/ml、85.4%>20 IU/ml,而未孕期接种者仅37%和21%。
要点
- 孕期接种百日咳疫苗可显著提高母体抗PT IgG水平。
- 近期接种者抗体滴度可达较早接种或未接种者的12-15倍。
- 孕期接种是保障新生儿早期免疫保护的有效策略。
核心结论
- 孕期接种百日咳疫苗能有效确保加强接种后最初数月内的高抗体滴度,与较早接种或从未接种者差异显著。
主要发现
- 近期接种者抗体滴度显著高于5年前以上接种或从未接种者(p<0.0001),甚至高达12-15倍。
- 近期接种者中95.1%抗PT IgG>10 IU/ml、85.4%>20 IU/ml,而未孕期接种组相应比例仅为37%和21%。
临床怎么用
- 研究支持在孕期为孕妇接种百日咳疫苗,以提升母体抗体水平并降低新生儿感染风险。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pertussis (whooping cough) is a highly infectious disease caused by Bordetella pertussis. Mothers lacking adequate immunity and contracting the disease represent the biggest risk of transmission to new-borns, for which the disease is often a threat. The aim of the study was to estimate the frequency of pertussis susceptibility among pregnant women, in order to point out the need for a vaccine recall during pregnancy, and to evaluate the antibody response in already vaccinated women. A cross-sectional observational study was conducted in the blood test centre of "St. Anna" Obstetrics and Gynaecology Hospital in Turin (Piedmont, Italy). Eligibility criteria included pregnant women coming to the centre for any blood test, aged 18 or above and with gestational age between 33 and 37 weeks at the moment of the blood draw. The data collection was carried out from May 2019 to January 2020 and the concentration of anti-Pertussis Toxin (anti-PT) IgG was measured through the Enzyme-Linked Immunosorbent Assay (ELISA) technique. Two-hundred women (median age 35) were enrolled: 132 (66%) had received at least one dose of pertussis vaccine, 82 of which during pregnancy. Recently vaccinated women had significantly higher antibody titres (even 12-15 times as high) compared to those vaccinated more than 5 years before or never vaccinated at all (p < 0.0001). Moreover, 95.1% of recently vaccinated women had anti-PT IgG levels above 10 IU/ml, and 85.4% above 20 IU/ml, while the same proportions were as low as 37% and 21% (respectively) in the group of women not vaccinated in pregnancy. This study confirmed that the vaccination is greatly effective in ensuring high antibody titres in the first months after the booster vaccine, with considerable differences in anti-PT IgG compared to women vaccinated earlier or never vaccinated at all, and therefore vaccinating pregnant women against pertussis still represents a valuable strategy.
引用
- Garlasco J, Bordino V, Marengo N, et al. Pertussis immunisation during pregnancy: Antibody levels and the impact of booster vaccine. Vaccine. 2021. PMID: 34330557. doi:10.1016/j.vaccine.2021.07.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。